Linked Life Data

19578014

Source:http://linkedlifedata.com/resource/pubmed/id/19578014

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19578014rdf:typepubmed:Citationlld:pubmed
pubmed-article:19578014lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0005847lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0035335lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0242184lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:19578014lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:19578014pubmed:issue12lld:pubmed
pubmed-article:19578014pubmed:dateCreated2009-12-3lld:pubmed
pubmed-article:19578014pubmed:abstractTextThe purpose of this study was to evaluate the effects of vessel targeting and chemotherapy agents on inducing hypoxic regions in LH(BETA)T(AG) murine retinal tumors. METHODS. Twelve- and 16-week-old LH(BETA)T(AG) transgenic retinoblastoma mice were treated with periocular injections to the right eye only of saline (n = 42), anecortave acetate (a single injection; 300 microg/20 microL; n = 42), or carboplatin (two injections per week for 3 weeks; 62.5 microg/20 microL; n = 42). Eyes were enucleated 1 day, 1 week, and 1 month after injection. To assess hypoxia, mice received 60 mg/kg pimonidazole via intraperitoneal injection. Eyes were enucleated, and tumor sections were analyzed.lld:pubmed
pubmed-article:19578014pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:languageenglld:pubmed
pubmed-article:19578014pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:citationSubsetIMlld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19578014pubmed:statusMEDLINElld:pubmed
pubmed-article:19578014pubmed:monthDeclld:pubmed
pubmed-article:19578014pubmed:issn1552-5783lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:FeuerWilliam...lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:MurrayTimothy...lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:CebullaCollee...lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:LampidisTheod...lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:JockovichMari...lld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:PiñaYolandaYlld:pubmed
pubmed-article:19578014pubmed:authorpubmed-author:BoutridHindaHlld:pubmed
pubmed-article:19578014pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19578014pubmed:volume50lld:pubmed
pubmed-article:19578014pubmed:ownerNLMlld:pubmed
pubmed-article:19578014pubmed:authorsCompleteYlld:pubmed
pubmed-article:19578014pubmed:pagination5537-43lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:meshHeadingpubmed-meshheading:19578014...lld:pubmed
pubmed-article:19578014pubmed:year2009lld:pubmed
pubmed-article:19578014pubmed:articleTitleIncreased hypoxia following vessel targeting in a murine model of retinoblastoma.lld:pubmed
pubmed-article:19578014pubmed:affiliationDepartment of Ophthalmology, Bascom Palmer Eye Institute, Miami, FL 33101, USA.lld:pubmed
pubmed-article:19578014pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19578014pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19578014pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19578014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19578014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19578014lld:pubmed